Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.75

-$0.11 (-5.91%)

At close: Oct 30, 2026, 4:00 PM ET

$1.85

+$0.10 (+5.71%)

After-hours: Oct 30, 2026, 7:31 PM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024
PE Ratio	-22.17	-76.83	-491.57	-802.75	0	-1.01K	-4.32K	-615.13Qu
PEG Ratio	0.47	-1.09	-1.56	-18.50	0	-1.77	1.77K	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	11.74	143.48	362.98	1.25K	2.04K	1.56K	1.41K	n/a
P/FCF Ratio	-22.11	-80.40	-536.95	-2.7K	n/a	-4.22K	-7.71K	n/a
P/OCF Ratio	-22.11	-80.40	-536.95	-2.7K	n/a	-4.22K	-7.71K	n/a
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Quick Ratio	13.53	3.45	8.55	8.77	11.97	23.99	17.30	n/a
Current Ratio	13.53	3.45	8.55	8.77	11.97	23.99	17.30	n/a
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-12.62%	-102.25%	-32.75%	-26.98%	-31.04%	-118.79%	-15.34%	n/a
Return on Assets	-11.68%	-72.64%	-27.58%	-23.90%	-28.45%	-113.84%	-14.46%	n/a
Return on Invested Capital	-12.62%	-78.70%	-18.92%	-18.37%	-27.23%	-118.79%	-15.34%	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a